CPEB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.717400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.670000E-01
Normal-vs-Stage2
8.155000E-01
Normal-vs-Stage3
1.145210E-01
Normal-vs-Stage4
8.531400E-01
Stage1-vs-Stage2
5.898000E-01
Stage1-vs-Stage3
7.243800E-02
Stage1-vs-Stage4
7.126800E-01
Stage2-vs-Stage3
1.629020E-01
Stage2-vs-Stage4
9.019600E-01
Stage3-vs-Stage4
7.508100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.476400E-01
Normal-vs-AfricanAmerican
7.432800E-01
Normal-vs-Asian
4.021000E-01
Caucasian-vs-AfricanAmerican
2.220400E-01
Caucasian-vs-Asian
2.505600E-01
AfricanAmerican-vs-Asian
1.825170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.384800E-01
Normal-vs-Female
6.940000E-01
Male-vs-Female
5.458800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.778200E-01
Normal-vs-Age(41-60Yrs)
9.928200E-01
Normal-vs-Age(61-80Yrs)
7.022800E-01
Normal-vs-Age(81-100Yrs)
4.773200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.108000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.910200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.518200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.841040E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.202800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.079400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.809800E-01
Normal-vs-Daily Drinker
2.953800E-01
Normal-vs-Weekly Drinker
6.385200E-01
Normal-vs-Occasional Drinker
8.949400E-01
Normal-vs-Social Drinker
8.969000E-01
Non Drinker-vs-Daily Drinker
3.197800E-01
Non Drinker-vs-Weekly Drinker
8.953800E-01
Non Drinker-vs-Occasional Drinker
4.460000E-01
Non Drinker-vs-Social Drinker
4.414200E-01
Daily Drinker-vs-Weekly Drinker
5.449200E-01
Daily Drinker-vs-Occasional Drinker
1.203590E-01
Daily Drinker-vs-Social Drinker
1.171050E-01
Weekly Drinker-vs-Occasional Drinker
5.064000E-01
Weekly Drinker-vs-Social Drinker
5.012200E-01
Occasional Drinker-vs-Social Drinker
9.835400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.089700E-02
Normal-vs-Grade 2
1.209950E-02
Normal-vs-Grade 3
4.908300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.323200E-01
Grade 1-vs-Grade 3
4.049800E-01
Grade 1-vs-Grade 4
8.089700E-02
Grade 2-vs-Grade 3
5.996800E-01
Grade 2-vs-Grade 4
1.209950E-02
Grade 3-vs-Grade 4
4.908300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.120200E-01
Normal-vs-NonDiabetic
6.053200E-01
Diabetic-vs-NonDiabetic
7.438800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.237000E-01
Normal-vs-NoPancreatitis
6.499800E-01
Pancreatitis-vs-NoPancreatitis
4.964400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.796400E-01
Normal-vs-N1
8.589800E-01
N0-vs-N1
2.616400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.984000E-01
Normal-vs-TP53-NonMutant
6.590600E-01
TP53-Mutant-vs-TP53-NonMutant
9.855600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
